Impact of comorbidities on the first bDMARD effectiveness and retention rate after 2 years of follow-up in patients with Rheumatoid Arthritis. Data from the Spanish registry BIOBADASER
14/08/2023
J. Calvo Gutierrez1,2,3, C. López-Medina1,2,3, L. Otero-Varela4, A. Escudero Contreras1,2,3, R. Ortega Castro1,2,3, M. L. Ladehesa Pineda1,2,3, C. Campos Fernández5, P. Bernabéu6, C. Bohórquez7, A. García Dorta8, D. Ruiz-Montesinos9, M. Pombo-Suarez10, I. Ros11, F. Sánchez-Alonso4, I. Castrejon12
EULAR 2023
DOI: 10.1136/annrheumdis-2023-eular.5471
http://scientific.sparx-ip.net/archiveeular/?c=a&view=1&searchfor=biobadaser&item=2023POS1073